U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2001
194
Name Type Language
ALEMTUZUMAB
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Common Name English
alemtuzumab [INN]
Common Name English
ALEMTUZUMAB [MI]
Common Name English
ALEMTUZUMAB [USAN]
Common Name English
ALEMTUZUMAB (GENETICAL RECOMBINATION) [JAN]
Common Name English
GZ402673
Code English
LDP-03
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD52 (ANTIGEN)) (HUMAN-RAT MONOCLONAL CAMPATH-1H, .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Common Name English
ALEMTUZUMAB [VANDF]
Common Name English
LEMTRADA
Brand Name English
Alemtuzumab [WHO-DD]
Common Name English
ALEMTUZUMAB [PURPLE BOOK CDER]
Common Name English
CAMPATH-1H
Common Name English
ALEMTUZUMAB (GENETICAL RECOMBINATION)
JAN  
Common Name English
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULPHIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD52 (ANTIGEN)) (HUMAN-RAT MONOCLONAL CAMPATH-1H, .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Common Name English
GZ-402673
Code English
ALLO 647 [WHO-DD]
Common Name English
ALEMTUZUMAB [JAN]
Common Name English
ALEMTUZUMAB [MART.]
Common Name English
ALEMTUZUMAB [EMA EPAR]
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS MABCAMPTH (WITHDRAWN: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL)
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
LIVERTOX NBK548212
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
WHO-VATC QL01XC04
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
LIVERTOX NBK548212
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
EMA ASSESSMENT REPORTS LEMTRADA (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
FDA ORPHAN DRUG 107197
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
NDF-RT N0000175079
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
WHO-ATC L04AA34
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
NDF-RT N0000175659
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
WHO-ATC L01XC04
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
NCI_THESAURUS C72960
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
Code System Code Type Description
EVMPD
SUB12459MIG
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
USAN
LL-56
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
MESH
C096529
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
CAS
216503-57-0
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
LACTMED
Alemtuzumab
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
MERCK INDEX
m1492
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY Merck Index
DRUG CENTRAL
4909
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
DRUG BANK
DB00087
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
SMS_ID
100000089882
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
DAILYMED
3A189DH42V
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
FDA UNII
3A189DH42V
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
INN
8005
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
HSDB
8177
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
IUPHAR
6770
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
WIKIPEDIA
ALEMTUZUMAB
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
NCI_THESAURUS
C1681
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201587
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY
RXCUI
117055
Created by admin on Sat Dec 16 00:32:39 GMT 2023 , Edited by admin on Sat Dec 16 00:32:39 GMT 2023
PRIMARY RxNorm
ACTIVE MOIETY
ALEMTUZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966